Global Enzyme Linked Immunosorbent Assay (ELISA) Market to Surpass US$ 3,004.3 Million by 2030, Says Coherent Market Insights (CMI)

Pune, INDIA


Seattle, July 22, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global Enzyme Linked Immunosorbent Assay (ELISA) market is estimated to be valued at US$ 2,016.1 million in 2022 and is expected to exhibit a CAGR of 5.1% during the forecast period (2022-2030).

Key Trends and Analysis of the Global Enzyme Linked Immunosorbent Assay (ELISA) Market:

Increasing product launches by market players is expected to drive the global Enzyme Linked Immunosorbent Assay (ELISA) market over the forecast period. For instance, on March 03, 2020, Epitope Diagnostics, a medical device manufacturing company had launched immunoassay kits exclusively for the qualitative detection of COVID-19. These kits include The EDI Novel Coronavirus COVID-19 IgG ELISA Kit and EDI Novel Coronavirus COVID-19 IgM ELISA Kit. With proven results from clinical testing in China.

Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/1505

Key Market Takeaways:

Global Enzyme Linked Immunosorbent Assay (ELISA) market is expected to exhibit a CAGR of 5.1% during the forecast period due to increasing product launches by market players in the global Enzyme Linked Immunosorbent Assay (ELISA) market. For instance, on February 18, 2021, Agilent Technologies Inc., a manufacturing company of analytical instrumentation development had announced the launch of the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit intended for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma.

Among Method, the Indirect ELISA segment holds a dominant position, owing to increasing product launch by market players. For instance, On June 9, 2022, The Indian Agricultural Research Institute (ICAR)-National Research Centre on Equines, Hisar, India, had announced the launch of CAN-CoV-2 ELISA Kit. It is a sensitive and specific nucleocapsid protein based indirect ELISA kit for antibody detection against SARS-CoV-2 in Canines. The kit is made in India and a patent has been filed for the CAN-CoV-2 ELISA Kit.

Competitive Landscape:

Key players operating in the global Enzyme Linked Immunosorbent Assay (ELISA) market include Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Biomerieux S.A., Alpco, BioLegand, Inc., R&D Systems, Creative Diagnostics, Zeus Scientific, Inc., and Shenzhen YHLO Biotech Co., Ltd.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1505

Market Segmentation:

  • Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Method:
    • Direct ELISA
    • Indirect ELISA
    • Sandwich ELISA
    • Competitive ELISA
  • Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Application:
    • Vaccine Development
    • Immunology
    • Diagnostics
    • Toxicology
    • Drug Monitoring & Pharmaceutical Industry
    • Transplantation
  • Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Technology:
    • Chemiluminescent
    • Colorimetric
    • Fluorescent
  • Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Region/Country
        • South Africa
        • Central Africa
        • North Africa

Related Market Intelligence Reports:

Renal Biomarkers Market, By Biomarker Type (Functional Biomarker (Serum Creatinine, Serum Cystatin C, Urine Albumin), Up-Regulated Proteins (Neutrophil gelatinase-associated lipocalin, Kidney injury molecule 1, Interleukin 18), Others), By Technique (Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay, Liquid Chromatography-Mass Spectrometry), By End User (Diagnostic Labs, Outpatient Clinics, Research Centers, Hospitals), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

Monoclonal Antibody Diagnostic Reagents Market, by Diagnostic Tests (Dot-immunogold Filtration Assay, Double Antigen Sandwich Chemiluminescence Method, Enzyme Linked Immunosorbent Assay, and Recombinant Immunoblot Assay), by Application (Hormones Diagnosis, Tumor Monitoring, Virus Detection, and Others) and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022-2028

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Follow Us: LinkedInTwitter

 

Contact Data